Gene expression analysis between c-Rel+ and c-Rel− DLBCL showed up- or downregulation of FOXP3 (Fig. 3F-3G), IL1B, IL3, IL6, IL10RA, IL12B, IL12RB1, IL17A, STAT3, JAK1/3, RUNX1/3, CXCR4, PRDM1, TP63, and CDKN1A (border-line P value) (Supplementary Fig. S4B-O) in c-Rel+versus c-Rel− DLBCL, either in the GCB or ABC subtype. The gene discussed is RUNX1; the disease is diffuse large B-cell lymphoma.